Home

Mangoceuticals, Inc. - Common Stock (MGRX)

1.8100
-0.2900 (-13.81%)
NASDAQ · Last Trade: Apr 27th, 5:16 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Detailed Quote

Previous Close2.100
Open1.820
Bid1.770
Ask1.810
Day's Range1.610 - 1.920
52 Week Range1.485 - 16.80
Volume3,740,478
Market Cap-
PE Ratio (TTM)-
EPS (TTM)-
Dividend & YieldN/A (N/A)
1 Month Average Volume392,422

Chart

About Mangoceuticals, Inc. - Common Stock (MGRX)

Mangoceuticals, Inc. is a biotechnology company focused on developing innovative wellness and lifestyle products that leverage the benefits of natural ingredients. The company specializes in formulating and marketing supplements aimed at enhancing men's health, vitality, and overall quality of life. By combining cutting-edge research with the power of nature, Mangoceuticals aims to provide consumers with effective and safe solutions for improving their well-being, all while promoting a healthier lifestyle. Through its commitment to quality and sustainability, the company seeks to establish itself as a leader in the health and wellness industry. Read More

News & Press Releases

Top stock movements in today's session.chartmill.com
Looking for insights into the US markets in the middle of the day on Friday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
Via Chartmill · April 25, 2025
Mangoceuticals Is Reengineering the Self-Care Blueprint with Better Personal Health and Wellness Solutions
MIAMI, FL / ACCESS Newswire / April 24, 2025 / For decades, the men's health space has remained largely stagnant-held back by legacy brands offering generic solutions and treatment protocols that too often felt like quick fixes rather than genuine care. The result has been an industry shaped by stigma, limited access, and minimal innovation.
Via ACCESS Newswire · April 24, 2025
Top movers in Wednesday's sessionchartmill.com
Curious about what's happening in today's session? Check out the latest stock movements and price changes.
Via Chartmill · April 23, 2025
Top movers analysis in the middle of the day on 2025-04-23: top gainers and losers in today's session.chartmill.com
Here are the top movers in Wednesday's session, showcasing the stocks with significant price changes.
Via Chartmill · April 23, 2025
Men's Telehealth Company's Plans To Change Men's Wellness
Men's Telehealth Company's Plans To Change Men's Wellness
Via News Direct · September 26, 2024
CEO Spotlight: How Mangoceuticals Inc. is Reinventing The Personal Health Landscape
DALLAS, TX / ACCESS Newswire / April 22, 2025 / Mangoceuticals Inc. (NASDAQ:MGRX) is on a mission to rewrite the playbook for men's performance, health, and vitality. Its pursuit comes at a time when opportunities have become enormous, with patent expirations on several of the world's most popular health and wellness drugs, opening vast pathways to exploit segmented market opportunities, each worth billions.
Via ACCESS Newswire · April 22, 2025
Top movers analysis one hour before the close of the markets on 2025-03-25: top gainers and losers in today's session.chartmill.com
Here are the top movers in Tuesday's session, showcasing the stocks with significant price changes.
Via Chartmill · March 25, 2025
Which stocks are experiencing notable movement on Tuesday?chartmill.com
Keep an eye on the top gainers and losers in Tuesday's session, as they reflect the most notable price movements.
Via Chartmill · March 25, 2025
MGRX Stock Earnings: Mangoceuticals Reported Results for Q2 2024investorplace.com
Mangoceuticals just reported results for the second quarter of 2024.
Via InvestorPlace · August 15, 2024
MangoRx Receives Request for Proposal (RFP) From ISFLST for New Male Enhancement Product Exclusive for the Asian Market
Dallas, TX Based Men's Health Telemedicine Company Announces Successful Participation in Beijing Exhibit
Via ACCESSWIRE · August 8, 2024
Let's uncover which stocks are experiencing notable gaps during today's session.chartmill.com
The market is buzzing with gapping stocks on Tuesday. Let's uncover which stocks are experiencing notable gaps during today's session.
Via Chartmill · March 25, 2025
12 Consumer Staples Stocks Moving In Friday's After-Market Sessionbenzinga.com
Via Benzinga · March 21, 2025
Top 3 Risk Off Stocks Which Could Rescue Your Portfolio This Quarterbenzinga.com
Via Benzinga · October 17, 2024
12 Consumer Staples Stocks Moving In Friday's Pre-Market Sessionbenzinga.com
Via Benzinga · October 11, 2024
12 Consumer Staples Stocks Moving In Thursday's After-Market Sessionbenzinga.com
Via Benzinga · October 10, 2024
12 Consumer Staples Stocks Moving In Tuesday's After-Market Sessionbenzinga.com
Via Benzinga · October 8, 2024
12 Consumer Staples Stocks Moving In Friday's After-Market Sessionbenzinga.com
Via Benzinga · October 4, 2024
11 Consumer Staples Stocks Moving In Friday's Intraday Sessionbenzinga.com
Via Benzinga · October 4, 2024
12 Consumer Staples Stocks Moving In Thursday's Pre-Market Sessionbenzinga.com
Via Benzinga · October 3, 2024
12 Consumer Staples Stocks Moving In Tuesday's Intraday Sessionbenzinga.com
Via Benzinga · October 1, 2024
Prescribing The Future: How MangoRx Is Shaking Up Telemedicine With A Fresh Platform
Prescribing The Future: How MangoRx Is Shaking Up Telemedicine With A Fresh Platform
Via News Direct · September 5, 2024
This Men’s Telehealth Company Has A Unique Take On Telehealth And Products
This Men’s Telehealth Company Has A Unique Take On Telehealth And Products
Via News Direct · July 25, 2024
Emerging Telemedicine Leaders: Stocks Shaping Healthcare's Digital Future
Emerging Telemedicine Leaders: Stocks Shaping Healthcare's Digital Future
Via News Direct · July 25, 2024
Erectile Function Vs Erectile Dysfunction: How MangoRx’s (NASDAQ: MGRX) Product Sets Itself Apart and Caters to a Large Market (Pun Intended)
Erectile Function Vs Erectile Dysfunction: How MangoRx’s (NASDAQ: MGRX) Product Sets Itself Apart and Caters to a Large Market (Pun Intended)
Via News Direct · July 10, 2024
Why Stitch Fix Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarketbenzinga.com
Via Benzinga · June 5, 2024